What are the major opportunities in the Biguanides market? What are the strategies for the Biguanides market?

For detailed insights on the major opportunities and strategies in the Biguanides market, Read More

How does the Biguanides market relate to the overall economy and other similar markets?

For detailed insights on Biguanides's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Biguanides market growth? SWOT analysis of the Biguanides market.

For detailed insights on the key dynamics influencing the Biguanides market growth and SWOT analysis of the Biguanides industry, Read More

Biguanides Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Biguanides Market Report 2026

Name: Biguanides Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Metformin, Phenformin, Other Types), By Dosage Form (Tablets, Oral Solutions), By Formulation (Immediate Release, Extended Release), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biguanides Market Overview

• Biguanides market size has reached to $5.11 billion in 2025

• Expected to grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 3.1%

• Growth Driver: Impact Of Rising Diabetes Prevalence On Biguanides

• Market Trend: Advancements In Extended-Release Biguanides For Enhanced Diabetes Management

• Asia-Pacific was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Biguanides Market?

Biguanides refer to a group of medications primarily used to treat type 2 diabetes. They help lower blood sugar levels by reducing the amount of sugar produced by the liver and improving the body's response to insulin. These medications are also used to treat polycystic ovary syndrome (PCOS) and other metabolic disorders.

The main types of biguanides are metformin, phenformin, and others. Metformin is a widely used biguanide medication that is used to treat type 2 diabetes by lowering blood sugar levels. Various dosage forms, including tablets and oral solutions in different formulations, such as immediate-release and extended-release, are provided through a variety of distribution channels, which include hospital pharmacies, retail pharmacies, and online pharmacies.

Biguanides Market Global Report 2026 Market Report bar graph

What Is The Biguanides Market Size and Share 2026?

The biguanides market size has grown steadily in recent years. It will grow from $5.11 billion in 2025 to $5.28 billion in 2026 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to increasing prevalence of type 2 diabetes, rising awareness of metabolic disorders, growth in generic biguanides availability, adoption of oral antidiabetic medications, advancements in liver-targeted therapies.

What Is The Biguanides Market Growth Forecast?

The biguanides market size is expected to see steady growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 3.1%. The growth in the forecast period can be attributed to growing demand for personalized medicine, expansion of telemedicine for diabetes care, rising incidence of pcOS, development of combination therapies, government initiatives promoting chronic disease management. Major trends in the forecast period include personalized diabetes management solutions, combination therapy development, expanded indications beyond type 2 diabetes, home healthcare & remote patient monitoring, cost-effective generic biguanides.

Book your 30 minutes free consultation with our research experts

Global Biguanides Market Segmentation

1) By Type: Metformin, Phenformin, Other Types

2) By Dosage Form: Tablets, Oral Solutions

3) By Formulation: Immediate Release, Extended Release

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

2) By Phenformin: Phenformin Hydrochloride

3) By Other Types: Buformin, Metformin Combinations

What Is The Driver Of The Biguanides Market?

The rise in diabetes is expected to propel the growth of the biguanides market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or impaired insulin function. The rise in diabetes is driven by lifestyle changes, population aging, and increased diagnostic awareness. The biguanides market supports diabetes management by improving insulin sensitivity, reducing hepatic glucose production, and helping lower blood sugar levels in individuals with type 2 diabetes. For instance, in March 2024, according to the Office for Health Improvement & Disparities (OHID), a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes it increased by 21%, and the proportion achieving target HbA1c levels reached 37.9%, the highest value ever reported. Therefore, the rising prevalence of diabetes is driving the growth of the biguanides industry.

Key Players In The Global Biguanides Market

Major companies operating in the biguanides market are Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

Global Biguanides Market Trends and Insights

Major companies operating in the biguanide market are focusing on developing advanced solutions such as extended-release biguanide formulations to improve patient compliance, enhance glycemic control, and minimize gastrointestinal side effects. Extended-release biguanide formulations refer to medications designed to release their active component gradually over time, maintaining stable blood concentrations, improving tolerability, and supporting better long-term adherence in individuals managing diabetes. For instance, in August 2023, Dr. Reddy’s Laboratories, an India-based biotechnology company, launched saxagliptin and metformin hydrochloride extended-release tablets, a USFDA-approved generic version of KOMBIGLYZE XR that combines saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide, offering adults with type 2 diabetes mellitus an effective once-daily treatment option that supports improved glycemic control when used alongside diet and exercise while enhancing adherence through its extended-release design.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Biguanides Market?

In August 2023, Lupin, an India-based biopharmaceutical company, acquired the diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim for an undisclosed amount. This acquisition strengthens Lupin’s position in the anti-diabetes segment by expanding its product portfolio with established oral antidiabetic therapies. It further enhances the company’s ability to improve patient access to essential diabetes medications and reinforces its competitive presence in the metabolic disorders market. Boehringer Ingelheim is a Germany-based biopharmaceutical company engaged in the research, development, and production of therapies for human and veterinary medicine.

Regional Insights

Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biguanides Market?

The biguanides market consists of sales of Chlorhexidine, Polyhexanide, Proguanil, and Buformin. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biguanides Market Report 2026?

The biguanides market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biguanides industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Biguanides Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.28 billion
Revenue Forecast In 2035	$5.97 billion
Growth Rate	CAGR of 3.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Dosage Form, Formulation, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries L
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Biguanides Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Biguanides Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Biguanides Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Biguanides Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Sustainability, Climate Tech & Circular Economy

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Personalized Diabetes Management Solutions

4.2.2 Combination Therapy Development

4.2.3 Expanded Indications Beyond Type 2 Diabetes

4.2.4 Home Healthcare & Remote Patient Monitoring

4.2.5 Cost-Effective Generic Biguanides

5. Biguanides Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Retail Pharmacies

5.4 Online Pharmacies

5.5 Diabetes Care Centers

6. Biguanides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biguanides Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Biguanides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Biguanides Market Size, Comparisons And Growth Rate Analysis

7.3. Global Biguanides Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Biguanides Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biguanides Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biguanides Market Segmentation

9.1. Global Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metformin, Phenformin, Other Types

9.2. Global Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablets, Oral Solutions

9.3. Global Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immediate Release, Extended Release

9.4. Global Biguanides Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Biguanides Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immediate-Release Metformin, Extended-Release Metformin

9.6. Global Biguanides Market, Sub-Segmentation Of Phenformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phenformin Hydrochloride

9.7. Global Biguanides Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Buformin, Metformin Combinations

10. Biguanides Market Regional And Country Analysis

10.1. Global Biguanides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Biguanides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biguanides Market

11.1. Asia-Pacific Biguanides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biguanides Market

12.1. China Biguanides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biguanides Market

13.1. India Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biguanides Market

14.1. Japan Biguanides Market Overview

14.2. Japan Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biguanides Market

15.1. Australia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biguanides Market

16.1. Indonesia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biguanides Market

17.1. South Korea Biguanides Market Overview

17.2. South Korea Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biguanides Market

18.1. Taiwan Biguanides Market Overview

18.2. Taiwan Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biguanides Market

19.1. South East Asia Biguanides Market Overview

19.2. South East Asia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biguanides Market

20.1. Western Europe Biguanides Market Overview

20.2. Western Europe Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biguanides Market

21.1. UK Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biguanides Market

22.1. Germany Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biguanides Market

23.1. France Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biguanides Market

24.1. Italy Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biguanides Market

25.1. Spain Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biguanides Market

26.1. Eastern Europe Biguanides Market Overview

26.2. Eastern Europe Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biguanides Market

27.1. Russia Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biguanides Market

28.1. North America Biguanides Market Overview

28.2. North America Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biguanides Market

29.1. USA Biguanides Market Overview

29.2. USA Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biguanides Market

30.1. Canada Biguanides Market Overview

30.2. Canada Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biguanides Market

31.1. South America Biguanides Market Overview

31.2. South America Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biguanides Market

32.1. Brazil Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biguanides Market

33.1. Middle East Biguanides Market Overview

33.2. Middle East Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biguanides Market

34.1. Africa Biguanides Market Overview

34.2. Africa Biguanides Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biguanides Market Regulatory and Investment Landscape

36. Biguanides Market Competitive Landscape And Company Profiles

36.1. Biguanides Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Biguanides Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Biguanides Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Aurobindo Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Cipla Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Biguanides Market Other Major And Innovative Companies

Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

38. Global Biguanides Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biguanides Market

40. Biguanides Market High Potential Countries, Segments and Strategies

40.1 Biguanides Market In 2030 - Countries Offering Most New Opportunities

40.2 Biguanides Market In 2030 - Segments Offering Most New Opportunities

40.3 Biguanides Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Biguanides Market, Overview Of Key Products - Product Examples

Table 2: Global Biguanides Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Biguanides Market, Supply Chain Analysis

Table 4: Global Biguanides Market, Major Raw Material Providers

Table 5: Global Biguanides Market, Major Resource Providers

Table 6: Global Biguanides Market, Major Manufacturers (Suppliers)

Table 7: Global Biguanides Market, Major Distributors And Channel Partners

Table 8: Global Biguanides Market, Key Technologies & Future Trends

Table 9: Global Biguanides Market, Major Trends

Table 10: Global Biguanides Market, Major End Users

Table 11: Global Biguanides Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Biguanides Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Biguanides Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Biguanides Market - TAM, US$ Billion, 2025

Table 15: Global Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Biguanides Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Biguanides Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Biguanides Market, Sub-Segmentation Of Phenformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Biguanides Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Biguanides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Biguanides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Biguanides Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Biguanides Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Sanofi-Aventis LLC Financial Performance

Table 100: Viatris Inc. Financial Performance

Table 101: Aurobindo Pharma Ltd. Financial Performance

Table 102: Cipla Ltd Financial Performance

Table 103: Global Biguanides Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Biguanides Market, Competitive Dashboard

Table 105: Global Biguanides Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Biguanides Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Biguanides Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030

Table 108: Global, Biguanides Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

List Of Figures

Figure 1: Global Biguanides Market, Overview Of Key Products - Product Examples

Figure 2: Global Biguanides Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Biguanides Market, Supply Chain Analysis

Figure 4: Global Biguanides Market, Major Raw Material Providers

Figure 5: Global Biguanides Market, Major Resource Providers

Figure 6: Global Biguanides Market, Major Manufacturers (Suppliers)

Figure 7: Global Biguanides Market, Major Distributors And Channel Partners

Figure 8: Global Biguanides Market, Key Technologies & Future Trends

Figure 9: Global Biguanides Market, Major Trends

Figure 10: Global Biguanides Market, Major End Users

Figure 11: Global Biguanides Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Biguanides Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Biguanides Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Biguanides Market - TAM, US$ Billion, 2025

Figure 15: Global Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Biguanides Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Biguanides Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Biguanides Market, Sub-Segmentation Of Phenformin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Biguanides Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Biguanides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Biguanides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Biguanides Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Biguanides Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Biguanides Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Sanofi-Aventis LLC Financial Performance

Figure 100: Viatris Inc. Financial Performance

Figure 101: Aurobindo Pharma Ltd. Financial Performance

Figure 102: Cipla Ltd Financial Performance

Figure 103: Global Biguanides Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Biguanides Market, Competitive Dashboard

Figure 105: Global Biguanides Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Biguanides Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Biguanides Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030

Figure 108: Global, Biguanides Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Conformal Coatings Market 2023 – By Type (Acrylic, Silicone, Epoxy, Urethane, Parylene, Other Types), By Technology (Water-Based, Solvent-Based, UV-Cured), By Operation Method (Dip Coating, Brush Coating, Spray Coating, ...

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2026 - Global Outlook – By Treatment Type (Symptomatic Drug Therapy, Supportive Care Therapy, Palliative Care), By Symptom Management (Seizure Management,...

Virtual Event Platform Market Report 2026 - Global Outlook – By Component (Platform, Services, Training And Consulting, Support And Maintenance, Deployment And Integration), By Organization Size (Large Enterprises, Mediu...

Ophthalmic Eye Dropper Market Report 2026 - Global Outlook – By Eye Dropper (Unidose Eye Dropper, Preserved Multi-Dose Eye Dropper, Preservative-Free Multi-Dose Eye Dropper), By Drug Type (Prescription Drugs, Over-The-Co...

Pesticide Inert Ingredients Market Report 2026 - Global Outlook – By Type (Emulsifiers, Solvents, Carriers, Other Types), By Source (Synthetic, Bio-based), By Form (Dry, Liquid, Other Forms), By Pesticide Types (Insectic...

Dental Restorative And Regenerative Material Market Report 2026 - Global Outlook – By Type (Restorative Material, Regenerative Material), By Material Composition (Composite Resins, Ceramics And Porcelain, Glass Ionomer C...

Aerospace And Defense Telemetry Market Report 2026 - Global Outlook – By Type (Radio, Satellite), By Equipment (Data Acquisition Unit, Telemetry Transmitters, Flight Terminator Receivers), By Component (Control device, D...

Frequently Asked Questions

How big is the Biguanides Market?

The Biguanides market was valued at $5.11 billion in 2025, increased to $5.28 billion in 2026, and is projected to reach $5.97 billion by 2030.

What is the Biguanides market growth?

The global Biguanides market is expected to grow at a CAGR of 3.1% from 2026 to 2035 to reach $5.97 billion by 2035.

Who are the key players in Biguanides market?

Some Key Players in the Biguanides market Include, Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuti

Major trend in this market includes: Advancements In Extended-Release Biguanides For Enhanced Diabetes Management. For further insights on this market. request a sample here

Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, So

Book your 30 minutes free consultation with our research experts

Contact Us